• For Researchers

The switch and the Trojan horse: how viral vectors and synthetic enhancers could change glioblastoma treatment

Advances in viral gene delivery – and a side project that paid off – have sent a highly targeted glioblastoma immunotherapy heading toward the clinic... Advances in viral gene delivery – and a side project that paid off – have sent a highly targeted glioblastoma immunotherapy heading toward the clinic...

6 January 2026

• Science & Technology
• Health & Medicine
• Policy & Insight

My 2026 predictions: Research, reform and the future of supporter engagement

Our Chief Executive, Michelle Mitchell, shares her top 5 predictions for 2026 and beyond in cancer research. Our Chief Executive, Michelle Mitchell, shares her top 5 predictions for 2026 and beyond in cancer research.

22 December 2025

• Policy & Insight

From labs to legislation - 9 impactful steps forward for cancer policy in 2025

Its been a busy and important year for cancer research policy, we're looking back at our 9 proudest steps forward in 2025. Its been a busy and important year for cancer research policy, we're looking back at our 9 proudest steps forward in 2025.

19 December 2025

• Charity News

Meet the brave children launching our Star Awards

19 December 2025

• Science & Technology
• Health & Medicine

Our defining research stories of 2025

2025 has been a huge year for research at Cancer Research UK. To celebrate, we've brought together our most defining research stories of the year. 2025 has been a huge year for research at Cancer Research UK. To celebrate, we've brought together our most defining research stories of the year.

19 December 2025

• For Researchers

Up and running – how can we make clinical trial set-up times faster?

The UK is ideally suited for early phase oncology trials, so is it possible to speed up set-up time? Sharan Sandhu tells us how we could... The UK is ideally suited for early phase oncology trials, so is it possible to speed up set-up time? Sharan Sandhu tells us how we could...

15 December 2025

• Health & Medicine

Cancer waiting times: Latest updates and analysis

Get the latest updates and analysis on NHS cancer waiting times in England, and learn what it means for people affected by cancer Get the latest updates and analysis on NHS cancer waiting times in England, and learn what it means for people affected by cancer

11 December 2025

• Policy & Insight

A historic step towards a smokefree Wales

A significant milestone for our Smokefree UK campaign, as Members of the Senedd (MSs) voted in favour of applying the Tobacco and Vapes Bill to Wales through a legislative consent motion. A significant milestone for our Smokefree UK campaign, as Members of the Senedd (MSs) voted in favour of applying the Tobacco and Vapes Bill to Wales through a legislative consent motion.

10 December 2025

• For Researchers

In the driving seat: Samra Turajlić on data ethics, cancer evolution and patient-centred research

We caught up with newly appointed Director of the CRUK Manchester Institute, Samra Turajlić to talk data ethics, cancer evolution and the future of patient care… We caught up with newly appointed Director of the CRUK Manchester Institute, Samra Turajlić to talk data ethics, cancer evolution and the future of patient care…

9 December 2025

• Health & Medicine

First steps towards a targeted prostate cancer screening programme

The UK NSC's proposed programme would invite 45 to 61-year-old men with BRCA mutations for prostate cancer screening every two years. Here's what it means and what will happen next. The UK NSC's proposed programme would invite 45 to 61-year-old men with BRCA mutations for prostate cancer screening every two years. Here's what it means and what will happen next.

28 November 2025